Cost-effectiveness of adenotonsillectomy in reducing obstructive sleep apnea, cerebrovascular ischemia, vaso-occlusive pain, and ACS episodes in pediatric sickle cell disease

The cost of health care for children and adults with sickle cell disease

Teresa L. Kauf, Thomas D. Coates, Huazhi Liu et al. · American Journal of Hematology · 2009 · 381 citations · Full text

Total Cost, Scd Complications, Health Care Finance +18

National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease

Otis W. Brawley, Llewellyn J. Cornelius, Linda Edwards et al. · Annals of Internal Medicine · 2008 · 269 citations

Hydroxyurea Treatment, Immunohematology, Translational Medicine +15

A comparison of multivariable regression models to analyse cost data

Susanna Dodd, Asish Bassi, Keith Bodger et al. · Journal of Evaluation in Clinical Practice · 2006 · 170 citations

Applied Economics, Objectives Analysis, Multivariable Regression Models +22

Medical care utilization and mortality in sickle cell disease: A population-based study

Sadhna Shankar, Patrick G. Arbogast, Ed Mitchel et al. · American Journal of Hematology · 2005 · 149 citations

Validation of diagnostic codes for outpatient‐originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data

Sean Hennessy, Charles E. Leonard, Cristin P Freeman et al. · Pharmacoepidemiology and Drug Safety · 2009 · 135 citations · Full text